Latest Advances

  • Condition: Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
  • Journal: Frontiers in public health
  • Treatment Used: EGFR-Tyrosine Kinase Inhibitors (TKIs) Combined with Traditional Chinese Medicine (TCM)
  • Number of Patients: 91
  • Published —
This study explored the effectiveness between of EGFR-tyrosine kinase inhibitors (TKIs) combined with traditional Chinese medicine (TCM) in patients with non-small cell lung cancer (NSCLC) with EGFR mutations.
  • Condition: Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Advances in respiratory medicine
  • Treatment Used: Immune Checkpoint Inhibitor (ICPI) Rechallenge
  • Number of Patients: 1
  • Published —
This case report describes a patient with non-small cell lung cancer (NSCLC) treated with rechallenge immune checkpoint inhibitor (ICPI).
  • Condition: Patients with Chronic Obstructive Pulmonary Disease (COPD) after Lobectomy due to Non-Small Cell Lung Cancer (NSCLC)
  • Journal: Advances in respiratory medicine
  • Treatment Used: Pulmonary Rehabilitation (PR)
  • Number of Patients: 37
  • Published —
This study evaluated the effectiveness of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) after lobectomy due to non-small cell lung cancer (NSCLC).
  • Condition: Small Cell Lung Cancer (SCLC)
  • Journal: Medical oncology (Northwood, London, England)
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
This article discusses the use of immunotherapy in the treatment of patients with small cell lung cancer (SCLC).
  • Condition: EGFR Driver Gene Positive Advanced Lung Cancer
  • Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • Treatment Used: Targeted Therapy, Chemotherapy, Antiangiogenic Agents, and Local Radiotherapy
  • Number of Patients: 0
  • Published —
This case report describes a patient with advanced lung cancer treated with targeted therapy, chemotherapy, antiangiogenic agents and local radiotherapy.
  • Condition: Patients with Stage I-IIIA Non-small Cell Lung Cancer in Louisiana
  • Journal: Frontiers in public health
  • Treatment Used: Surgery
  • Number of Patients: 3616
  • Published —
This study examined the potential racial disparity on receipt of timely surgery among patients with lung cancer in Louisiana.
  • Journal: Nature communications
  • Published —
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.
  • Journal: Dermatology online journal
  • Published —
Gefitinib-associated lichen planus pigmentosus-like eruption.
  • Condition: Severe Nivolumab-Induced Adverse Events Refractory to Immunosuppressive Therapy in Patient with Lung Cancer
  • Journal: Medicine
  • Treatment Used: Prednisolone, Mycophenolate Mofetil, and Tacrolimus Combination Therapy
  • Number of Patients: 5
  • Published —
This case report describes a 64-year-old male with Stage IV squamous cell lung carcinoma who developed severe nivolumab-induced adverse events similar to primary sclerosing cholangitis (bile duct inflammation) refractory to immunosuppressive therapy treated with prednisolone, mycophenolate mofetil, and tacrolimus combination therapy.
  • Journal: Current treatment options in oncology
  • Published —
Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.
  • Journal: European review for medical and pharmacological sciences
  • Published —
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as mortality predictor of advanced stage non-small cell lung cancer (NSCLC) with COVID-19 in Indonesia.
  • Journal: BMJ open
  • Published —
Can 18F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis.
Showing 1-12 of 1343